Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients

Transplantation Proceedings

Volumn 35, Issue 2, 2003, Pages 609-611

  Ben Ari, Z ^a   Mor, E ^b   Bar Nathan, N ^b   Shaharabani, E ^b   Shapira, Z ^b   Tur Kaspa, R ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; HEPATECT R; HEPATITIS B ANTIBODY; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; CLINICAL PROTOCOL; CONFERENCE PAPER; FEMALE; GRAFT REJECTION; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RECIPIENT; RECURRENT INFECTION; TREATMENT OUTCOME;

EID: 0037339305     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00008-3     Document Type: Conference Paper

References (12)

1. O'Grady J.G., Smith H.M., Davies S.E., et al. J Hepatol. 14:1992;104.
2. Samuel D., Muller R., Alexander G., et al. N Engl J Med. 329:1993;1842.
3. Ghany M.G., Ayala B., Villamil F.G., et al. Hepatology. 27:1998;213.
4. Dienstag J.L., Perrillo R.P., Schiff E.R., et al. N Engl J Med. 333:1995;1657.
5. Grellier L., Mutimre D., Ahmed M., et al. Lancet. 348:1996;1212.
6. Ling R., Mutimer D., Ahmed M., et al. Hepatology. 24:1996;711.
7. Perrillo R., Rakela J., Dienstag J., et al. Hepatology. 29:1999;1581.
8. Ben-Ari Z., Mor E., Shapira Z., et al. Liver Transplant. 7:2001;113.
9. Tur-Kaspa R., Klein A., Aharonson S.H., et al. Hepatology. 16:1992;1338.
10. Tipples G.A., Ma M.M., Fischer K.P., et al. Hepatology. 24:1996;714.
11. Yoshida E.M., Erb S.R., Partovi N., et al. Liver Transplant. 5:1999;520.
12. Markowitz J.S., Martin P., Conrad A.Y., et al. Hepatology. 28:1998;585.